CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring ...

RDT, a leading provider of pre-hospital care solutions, will be previewing its Tempus ALS™ defibrillator monitor at MEDICA 2016. Visitors to Stand D70 in Hall 11 will be able to see this innovative ...

Remote Diagnostic Technologies Ltd. (RDT), an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham.

Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECG-Low ...